Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bush warning on drug rationing; Democrats' offensive; Sharing secrets at CDER

President Bush and top administration officials last week launched a summer offensive against efforts by Democrats to portray Republicans as stingy lap dogs for big pharma, and he implicitly criticized members of his own party who are attacking drug company profits.

The president tried to widen the scope of discussions about access, arguing that while the Democrats' Medicare plans appear more generous than Republican legislation passed by the House, in the long run they actually would limit access to drugs. Countering attacks by Sens. Paul Wellstone (D-Minn.) and John McCain (R-Ariz.) on drug company profits, the White House released a report on the importance of private sector investments in developing new therapies.

In the administration's clearest statement to

Read the full 1189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers